We are live on ! Find out more
CC

Caxton Corporation Portfolio holdings

AUM $4.02M
1-Year Est. Return 256.08%
This Fund
S&P 500
This Quarter Est. Return
+7.64%
1 Year Est. Return
+256.08%
3 Year Est. Return
+777.99%
5 Year Est. Return
+744.68%
10 Year Est. Return
+18,621.85%
AUM
$283M
AUM Growth
+$191M
Cap. Flow
+$202M
Cap. Flow %
71.4%
Top 10 Hldgs %
97.95%
Holding
31
New
8
Increased
5
Reduced
7
Closed
6

Top Buys

Rank Stock Value
1
LITS
Lite Strategy Inc
LITS
+$13.5M
2
AMLP icon
Alerian MLP ETF
AMLP
+$4.25M
3
ICMB icon
Investcorp Credit Management BDC
ICMB
+$683K
4
MRKR icon
Marker Therapeutics
MRKR
+$432K
5
KURA icon
Kura Oncology
KURA
+$278K

Top Sells

Rank Stock Value
1
AGRX
Agile Therapeutics
AGRX
+$4.66M
2
SCYX icon
SCYNEXIS
SCYX
+$2.85M
3
FSK icon
FS KKR Capital
FSK
+$508K
4
BUD icon
AB InBev
BUD
+$486K
5
BBDC icon
Barings BDC
BBDC
+$258K

Sector Composition

Rank Sector Weight
1 Healthcare 22.26%
2 Financials 3.51%
3 Real Estate 0.53%
4 Industrials 0.34%
5 Utilities 0.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ADNT icon
26
Adient
ADNT
$1.55B
– –
-3,838
Closed -$229K
BUD icon
27
AB InBev
BUD
$156B
– –
-4,425
Closed -$486K
FSK icon
28
FS KKR Capital
FSK
$3.06B
– –
-17,529
Closed -$508K
MDGL icon
29
Madrigal Pharmaceuticals
MDGL
$12.8B
– –
-1,999
Closed -$233K
AGRX
30
DELISTED
Agile Therapeutics
AGRX
– –
-907
Closed -$4.66M
DRNA
31
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
– –
-13,074
Closed -$125K
1
2

Similar funds

PCM
Pathway Capital Management Irvine, California $4.3M AUM 62.8% 1-Year Est. Return
EAMS
Eurizon Asset Management Slovakia Bratislava $3.4M AUM
RCP
RPM Capital Partners New York $3.34M AUM 43.17% 1-Year Est. Return
RA
Ritter Alpha New York $4.78M AUM
CGA
Compound Global Advisors Mercer Island, Washington $3.22M AUM 30.08% 1-Year Est. Return
HFA
Harbert Fund Advisors Birmingham, Alabama $3.03M AUM 40.55% 1-Year Est. Return
ABA
American Beacon Advisors Irving, Texas $5.08M AUM 20.11% 1-Year Est. Return
UOMF
University of Maryland Foundation Adelphi, Maryland $5.1M AUM 10.69% 1-Year Est. Return

Caxton Corporation's Q2 2018 Portfolio in Review

As of Q2 2018, Caxton Corporation held 31 positions worth $283M, up 207% from $92.1M the previous quarter. Its ten largest holdings account for 98% of the portfolio.

Caxton Corporation deployed $202M of net new capital in Q2 2018, opening 8 new positions and adding to 5 existing holdings. Its largest new stake was Lite Strategy Inc: 220,022 shares worth $17.3M.

By sector, the portfolio is most concentrated in Healthcare at 22% of assets, down from 70% a quarter earlier, followed by Financials and Real Estate.

On the sell side, the largest reduction was SCYNEXIS, an estimated $2.85M trimmed.

  • Caxton Corporation's largest Q2 2018 buy was Lite Strategy Inc: 220,022 shares worth $17.3M.
  • Caxton Corporation added most to Investcorp Credit Management BDC in Q2 2018, an estimated $683K increase.
  • Caxton Corporation's biggest Q2 2018 reduction was SCYNEXIS, cutting an estimated $2.85M.
  • Caxton Corporation fully exited Agile Therapeutics in Q2 2018, selling an estimated $4.66M.
  • Caxton Corporation's ten largest holdings make up 98% of its $283M portfolio in Q2 2018.
  • Caxton Corporation opened 8 new positions and closed 6 in Q2 2018.
  • Caxton Corporation's portfolio value rose 207% quarter-over-quarter to $283M.

Based on Caxton Corporation's 13F filing for Q2 2018, filed 14 Aug 2018.